医学
麻醉
感染性休克
重症监护
败血症
外科
重症监护医学
作者
Ross Freebairn,James L. Derrick,Charles D. Gomersall,Robert J. Young,Gavin M. Joynt
标识
DOI:10.1097/00003246-199701000-00015
摘要
Objective To investigate the influence of the neuromuscular blocking agent vecuronium on oxygen delivery (DO2), oxygen consumption (VO2), oxygen extraction ratio, and gastric intramucosal pH in heavily sedated patients with severe sepsis or septic shock. Design Prospective, randomized, placebo-controlled, crossover trial. Setting University hospital intensive care unit. Patients Eighteen mechanically ventilated patients with severe sepsis or septic shock. Interventions All patients were heavily sedated. After baseline measurement, a computer-controlled, closed-loop infusion of either vecuronium or saline was initiated and further measurements were made at 40 and 60 mins. The procedure was repeated with the alternative agent after return of neuromuscular function. Measurements and Main Results DO2, VO2, and intramucosal pH were monitored using pulmonary artery catheters, a gas exchange monitor, and gastric tonometers. Changes from baseline were compared (paired t-test, p = .05). The vecuronium closed-loop infusion achieved T1 between 5% and 15% at 40 mins. There was a significant difference in the changes from baseline for static respiratory compliance in the vecuronium closed-loop infusion group compared with the saline closed-loop infusion group. There was no significant difference in the change from baseline for systemic or pulmonary vascular resistance, DO2, VO2, oxygen extraction ratio, or intramucosal pH. Conclusions In these patients, vecuronium infusion achieved the targeted level of paralysis and improved respiratory compliance but did not alter intramucosal pH, VO2, DO2, or oxygen extraction ratios. With deep sedation, neuromuscular blockade in severe sepsis/septic shock does not significantly influence oxygen flux and should be abandoned as a routine method of improving tissue oxygenation in these patients. (Crit Care Med 1997; 25:72-77)
科研通智能强力驱动
Strongly Powered by AbleSci AI